Prognostic impact of blood transfusion in patients with metastatic non-small cell lung cancer receiving chemotherapy

Sakin A. , SAHIN S., YASAR N., DEMIR C., ARICI S., GEREDELI C., ...Daha Fazla

LUNG CANCER, cilt.133, ss.38-44, 2019 (SCI İndekslerine Giren Dergi) identifier identifier identifier


Purpose: To investigate the prognostic effects of Allogeneic Blood Transfusion (ABT) in patients with metastatic Non-Small Cell Lung Cancer (NSCLC) receiving Chemotherapy (CT) in the first-line treatment, comparing untransfused patients to those receiving blood transfusion during treatment period or before treatment period.